TDNA

T. Rowe Price Biotech ETF

25.49

Sep 17 • 4:00 PM ET 0.00 (0.00%)

Financial Exchange Traded Fund USA NASD

Sep 17, 10:05 AMT. Rowe Price Biotech ETF (TDNA) began trading on Nasdaq today as a new fully transparent, actively managed biotech fund with an expense ratio of 0.55%.

Category	-
Sponsor	-
Fund Family
Index	-
Index Weighting
Active/Passive
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Expense	-
Inverse/Leveraged
IPO	Sep 17, 2026

Asset Type	-
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short	No / No

Tags	-
Tags	-
Tags	-
Tags	-
Tags	-
Tags	-
Tags	-
Sector/Theme
Region
SMA20	0.00%
SMA50	0.00%
SMA200	0.00%

Return% 1Y	-
Return% 3Y	-
Return% 5Y	-
Return% 10Y
Return% SI
Flows% 1M	-
Flows% 3M	-
Flows% YTD	-
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades

Total Holdings	-
AUM	-
NAV/sh
52W High	25.64 -0.59%
52W Low	25.49 0.00%
Volatility	- -
ATR (14)	0.15
RSI (14)	-
Beta	-
Rel Volume	0.00
Avg Volume	0.78K
Volume	0

Perf Week	-
Perf Month	-
Perf Quarter	-
Perf Half Y	-
Perf YTD	-
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Prev Close	25.49
Price	25.49
Change %	0.00%

Sep-17-26 09:58AM

T. ROWE PRICE DEBUTS BIOTECH, SMALL-CAP, AND MID-CAP EXCHANGE TRADED FUNDS

(PR Newswire)

Actively managed ETF that invests at least 80% of net assets in biotechnology companies engaged in healthcare innovation, primarily U.S. common stocks of any market capitalization, using fundamental bottom-up analysis with a focus on new platform technologies and novel therapeutic approaches. Seeks long-term capital appreciation.

open in yahoo | open in marketwatch | open in google

TDNA

T. Rowe Price Biotech ETF

Upgrade your Finviz experience